Osaic Holdings’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.8K Sell
1,370
-55
-4% -$754 ﹤0.01% 5389
2025
Q1
$15.1K Buy
1,425
+364
+34% +$3.85K ﹤0.01% 5504
2024
Q4
$18K Buy
1,061
+392
+59% +$6.65K ﹤0.01% 5381
2024
Q3
$15.5K Sell
669
-1
-0.1% -$23 ﹤0.01% 5477
2024
Q2
$16.3K Sell
670
-208
-24% -$5.06K ﹤0.01% 5429
2024
Q1
$29.6K Sell
878
-94
-10% -$3.17K ﹤0.01% 5080
2023
Q4
$30.6K Sell
972
-739
-43% -$23.3K ﹤0.01% 5221
2023
Q3
$43.7K Buy
1,711
+41
+2% +$1.05K ﹤0.01% 5072
2023
Q2
$47.9K Sell
1,670
-136
-8% -$3.9K ﹤0.01% 4963
2023
Q1
$43.3K Sell
1,806
-175
-9% -$4.19K ﹤0.01% 5045
2022
Q4
$33K Sell
1,981
-332
-14% -$5.53K ﹤0.01% 5209
2022
Q3
$33K Sell
2,313
-138
-6% -$1.97K ﹤0.01% 5218
2022
Q2
$37K Sell
2,451
-70
-3% -$1.06K ﹤0.01% 5167
2022
Q1
$68K Sell
2,521
-606
-19% -$16.3K ﹤0.01% 4853
2021
Q4
$116K Sell
3,127
-871
-22% -$32.3K ﹤0.01% 4459
2021
Q3
$191K Sell
3,998
-487
-11% -$23.3K ﹤0.01% 3943
2021
Q2
$151K Sell
4,485
-20,846
-82% -$702K ﹤0.01% 4111
2021
Q1
$1.05M Buy
25,331
+20,508
+425% +$846K ﹤0.01% 2191
2020
Q4
$209K Buy
4,823
+1,813
+60% +$78.6K ﹤0.01% 3439
2020
Q3
$129K Buy
3,010
+1,263
+72% +$54.1K ﹤0.01% 3607
2020
Q2
$82K Buy
1,747
+1,147
+191% +$53.8K ﹤0.01% 3825
2020
Q1
$8K Buy
+600
New +$8K ﹤0.01% 5061